SCHEMBL4159052

SCHEMBL4159052

CN(C(=O)c1c(F)cccc1F)C(=O)N(C)c1ccccc1SC(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
TLR7 Q9NYK1 1/20 0.32
POLB P06746 1/20 0.32
RORC P51449 2/20 0.31
GPBAR1 Q8TDU6 3/20 0.31
FFAR4 Q5NUL3 1/20 0.30
HSD17B1 P14061 1/20 0.30
HSD17B2 P37059 1/20 0.30
KDM4E B2RXH2 1/20 0.30
PPIA P62937 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150843 0.85 POLB (0.36) TDP1CES2CES1TLR7POLB
SCHEMBL4155686 0.84 TDP1 (0.35) TDP1CES2CES1TLR7POLB
SCHEMBL4154435 0.81 RORC (0.36) TDP1HTTCES2CES1TLR7
SCHEMBL4149997 0.79 RORC (0.41) TDP1TLR7RORC
SCHEMBL4155292 0.79 RORC (0.38) TDP1HTTTLR7POLBRORC
SCHEMBL4159049 0.79 TLR7 (0.39) TDP1ALDH1A1CES2CES1TLR7
SCHEMBL4156749 0.78 POLB (0.37) TDP1ALDH1A1HTTCES2CES1
SCHEMBL4157351 0.75 TDP1 (0.33) TDP1TLR7RORCHSD17B1HSD17B2
SCHEMBL4158854 0.74 RORC (0.35) TDP1TLR7POLBRORCGPBAR1
SCHEMBL4162997 0.74 RORC (0.46) TLR7RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 TDP1 1690/4885L3MBTL1 8/4885ALDH1A1 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.